B細胞リンパ腫におけるアセチルトランスフェラーゼ遺伝子の不活性化変異
Laura Pasqualucci1, David Dominguez-Sola, Annalisa Chiarenza
1Institute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York 10032, USA. lp171@columbia.edu
Nature
|March 11, 2011
まとめ
遺伝子の活性を調節するCREBBPおよびEP300遺伝子の変異は,小胞性リンパ腫および拡散性大B細胞リンパ腫で一般的です. ヒストンアセチルトランスフェラーゼ (HAT) のこれらの変化がリンパ腫の発症に寄与する.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- B細胞非ホジキンリンパ腫 (NHL) は,遺伝子の変異によって引き起こされる多様な癌です.
- 重要な遺伝的病変には,腫瘍遺伝子と腫瘍抑制遺伝子が含まれています.
研究 の 目的:
- 卵泡リンパ腫 (FL) と拡散型大B細胞リンパ腫 (DLBCL) の病原性におけるCREBBPとEP300遺伝子の役割を調査する.
- 共通のB細胞NHLサブタイプにおける共通の遺伝的メカニズムを特定する.
主な方法:
- FLおよびDLBCL患者のサンプルにおけるCREBBPおよびEP300遺伝子のゲノム欠損および体変異の分析.
- ヒストンアセチルトランスファーゼ (HAT) 活性に対するこれらの変異の機能的影響の評価.
- BCL6オンコタンパク質とp53腫瘍抑制剤のアセチル化媒介調節の評価.
主要な成果:
- DLBCLの約39%,FLの約41%がCREBBPまたはEP300の不活性化変異または欠損を示しています.
- これらの遺伝的変異は,典型的には1つのアレルに影響し,HATの投与量を減らすことが重要であることを示唆しています.
- 変異により,BCL6オンコタンパク質の不活性化が低下し,p53腫瘍抑制剤の活性化が低下する.
結論:
- CREBBP/EP300変異は,一般的なB細胞NHLにおける重要な病原遺伝的メカニズムを表しています.
- これらの発見は,リンパ増生におけるHAT活動の重要性を強調しています.
- 結果は,アセチル化/デアセチル化経路を標的とした潜在的な治療戦略を示唆しています.
関連する概念動画
X-Inactivation
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Phase II Reactions: Acetylation Reactions
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...


